Results for tag: "Tafinlar"

Tafinlar is an oncology drug used to treat advanced melanoma, a type of skin cancer. It is a kinase inhibitor, meaning it works by blocking certain proteins that help cancer cells grow and divide. Tafinlar is usually used in combination with Mekinist, another kinase inhibitor, to treat advanced melanoma. It is also used to treat non-small cell lung cancer and renal cell carcinoma. Tafinlar is a prescription drug and is available in tablet form. It is typically taken twice a day, with or without food. Common side effects include nausea, vomiting, diarrhea, fatigue, and rash. The Tafinlar market is a rapidly growing segment of the oncology drug market. It is driven by the increasing prevalence of melanoma and other types of cancer, as well as advances in drug development and delivery. Some companies in the Tafinlar market include Novartis, Merck, and GlaxoSmithKline. Show Less Read more